Gene · 5300
Papers3,752
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,752
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Key Genes and Immune Characteristics of SASP in Acute Ischemic Stroke. | J Mol Neurosci | 2025 | 39960563 | PubTator, text mining | PubMed |
| Effects of D-Amino Acid Replacements on the Conformational Stability of Miniproteins. | Chembiochem | 2025 | 39948034 | PubTator, text mining | PubMed |
| Pin1 as a central node in oncogenic signaling: Mechanistic insights and clinical prospects (Review). | Mol Med Rep | 2025 | 39886975 | PubTator, text mining | PubMed |
| Structure-Guided Optimization and Preclinical Evaluation of 6-O-Benzylguanine-Based Pin1 Inhibitor for Hepatocellular Carcinoma Treatment. | J Med Chem | 2025 | 39868498 | PubTator, text mining | PubMed |
| OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth. | Mol Cell | 2025 | 39862868 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| Discovery of Novel Pyrimidine Derivatives as Human Pin1 Covalent Inhibitors. | ACS Med Chem Lett | 2025 | 39811131 | PubTator, text mining | PubMed |
| PIN1 Prolyl Isomerase Promotes Initiation and Progression of Bladder Cancer through the SREBP2-Mediated Cholesterol Biosynthesis Pathway. | Cancer Discov | 2025 | 39808064 | PubTator, text mining | PubMed |
| USP34 regulates PIN1-cGAS-STING axis-dependent ferroptosis in cervical cancer via SUMOylation. | Int Immunopharmacol | 2025 | 39752760 | PubTator, text mining | PubMed |
| A comprehensive investigation of the impact of cross-linker backbone structure on protein dynamics analysis: A case study with Pin1. | Talanta | 2025 | 39736203 | PubTator, text mining | PubMed |
| A hitchhiker's guide to deep chemical language processing for bioactivity prediction. | Digit Discov | 2025 | 39726698 | PubTator, text mining | PubMed |
| The protein tyrosine phosphatase Lyp/PTPN22 drives TNFα-induced priming of superoxide anions production by neutrophils and arthritis. | Free Radic Biol Med | 2025 | 39724988 | PubTator, text mining | PubMed |
| Correction for Alboreggia et al., Targeted degradation of Pin1 by protein-destabilizing compounds. | Proc Natl Acad Sci U S A | 2025 | 39705324 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Overexpression of PIN1 in patients with severe COVID-19. | Diagn Microbiol Infect Dis | 2025 | 39616688 | PubTator, text mining | PubMed |
| A structure-based approach to discover a potential isomerase Pin1 inhibitor for cancer therapy using computational simulation and biological studies. | Comput Biol Chem | 2025 | 39586226 | PubTator, text mining | PubMed |
| Corrigendum to "Cobalt induces neurodegenerative damages through Pin1 inactivation in mice and human neuroglioma cells" [J Hazard Mater 419 (2021) 126378]. | J Hazard Mater | 2025 | 39572344 | PubTator, text mining | PubMed |
| Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma. | Cancer Gene Ther | 2025 | 39511416 | PubTator, text mining | PubMed |
| microRNA-324 mediates bone homeostasis and the regulation of osteoblast and osteoclast differentiation and activity. | Bone | 2025 | 39383985 | PubTator, text mining | PubMed |
| Amentoflavone Induces Ferroptosis to Alleviate Proliferation, Migration, Invasion and Inflammation in Rheumatoid Arthritis Fibroblast-like Synoviocytes by Inhibiting PIN1. | Cell Biochem Biophys | 2025 | 39354278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5300/papers?page=6